ANALYSIS OF A RANGE OF ABDOMINAL AND BOWEL SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA REPORTING INADEQUATE SYMPTOM CONTROL WITH LOPERAMIDE: RESULTS FROM ELUXADOLINE CLINICAL TRIALS

被引：0
|
作者：
Brenner, Darren M.
Sayuk, Gregory S.
Saeed, Mazen
Janiszewski, Peter
Liu, Louis W.
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1327
引用
收藏
页码：S851 / S851
页数：1
相关论文
共 50 条
  • [1] Effects of Eluxadoline on a Range of Bowel and Abdominal Symptoms in Patients With Irritable Bowel Syndrome With Diarrhea who Report Inadequate Symptom Control With Loperamide
    Brenner, Darren M.
    Sayuk, Gregory S.
    Elmes, Steven J. R.
    Saeed, Mazen
    Chey, William D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S273 - +
  • [2] SAFETY PROFILE OF ELUXADOLINE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA REPORTING INADEQUATE SYMPTOM CONTROL WITH PRIOR LOPERAMIDE USE: A PHASE 4 STUDY (RELIEF)
    Cash, Brooks D.
    Brenner, Darren M.
    Elmes, Steven
    Sayuk, Gregory S.
    Liu, Louis W.
    GASTROENTEROLOGY, 2019, 156 (06) : S91 - S92
  • [3] Effect of Eluxadoline on Abdominal and Bowel Symptoms Over Time in Phase 3 Clinical Trials in Patients With Irritable Bowel Syndrome With Diarrhea
    Harris, Lucinda
    Lucak, Susan
    Chang, Lin
    Dove, Leonard S.
    Covington, Paul S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S748 - S748
  • [4] Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study
    Brenner, Darren M.
    Sayuk, Gregory S.
    Gutman, Catherine R.
    Jo, Esther
    Elmes, Steven J. R.
    Liu, Louis W. C.
    Cash, Brooks D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (09): : 1502 - 1511
  • [5] Effects of Eluxadoline on Abdominal Pain in Patients With Irritable Bowel Syndrome With Diarrhea: Results of 2 Phase 3 Clinical Trials
    Lembo, Anthony
    Dove, Scott
    Andrae, David
    Turner, Lisa
    Davenport, J. Michael
    Covington, Paul S.
    GASTROENTEROLOGY, 2015, 148 (04) : S493 - S493
  • [6] ROBUSTNESS OF ELUXADOLINE FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA IN PATIENTS WHO REPORT INADEQUATE SYMPTOM CONTROL WITH PRIOR LOPERAMIDE USE: A PHASE 4 STUDY (RELIEF)
    Brenner, Darren M.
    Elmes, Steven
    Sayuk, Gregory S.
    Liu, Louis W.
    Cash, Brooks D.
    GASTROENTEROLOGY, 2019, 156 (06) : S90 - S91
  • [7] EFFECT OF ELUXADOLINE ON ABDOMINAL AND BOWEL SYMPTOMS OVER TIME IN PHASE 3 CLINICAL TRIALS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHOEA (IBS-D)
    Harris, L. A.
    Lucak, S.
    Chang, L.
    Dove, L. S.
    Covington, P. S.
    GUT, 2016, 65 : A122 - A123
  • [8] Improved work productivity and health-related quality of life in patients with irritable bowel syndrome with diarrhea receiving eluxadoline following inadequate response to loperamide
    Brenner, Darren M.
    Sayuk, Gregory S.
    Abel, Jessica L.
    Burslem, Kate
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (04): : 469 - 477
  • [9] Economic burden of inadequate symptom control among US commercially insured patients with irritable bowel syndrome with diarrhea
    Buono, Jessica L.
    Mathur, Kush
    Averitt, Amelia J.
    Andrae, David A.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (04) : 353 - 362
  • [10] Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis
    Lembo, Anthony J.
    Chey, William D.
    Harris, Lucinda A.
    Frazier, Rosita
    Brenner, Darren M.
    Chang, Lin
    Lacy, Brian E.
    Edelstein, Susan
    Yang, Yang
    Zhao, Suling
    Rosenbaum, David P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (05): : 937 - 945
12345